Antibody processing
Proteins and enzymes for antibody capture and characterization
Protein inputs for biopharmaceutical research and manufacturing.
Built for performance and high purity.
Made in the USA.

Parallel bioreactors · CUVIA, Mountain View, California
Products
Product data and evaluation material available on request.
Proteins and enzymes for antibody capture and characterization
Animal-free for cell culture media and cosmetics
Enzymes for nucleic-acid clearance and downstream bioprocessing
For imaging and assay development
Team
A small team spanning protein design, synthetic biology, process development, manufacturing, and application.
FAQ
CUVIA makes proteins - and builds the biology and manufacturing systems that make them better. Today, that means bioprocessing proteins used across antibody workflows, cell culture, nucleic-acid processing and research. The same platform expands toward biologics.
We engineer the molecule and the biological system that makes it, develop the process around both, and run the fermentation, recovery and purification ourselves. Because the same team carries a product from design through to supply, there is no technology handoff between development and manufacturing.
Yes. RUO (research use only) evaluation material is available for every product marked Samples available, alongside product data reported with the conditions under which each measurement was made. Performance depends on your format and process, so testing it directly in your own system is the measurement that matters.
Samples available means the product is available now, with product data and evaluation material on request. In qualification means that the product is being application tested. In development means it is in the pipeline.
CUVIA is based in Mountain View, California, and manufactures in the United States, in-house.
We have a broad pipeline. Talk to us about adding your molecule to our pipeline.
Get in touch
Product data and evaluation material are available on request. Technical questions go straight to the people who made the material.

Founder and Chief Executive Officer
A scientist and biomanufacturing leader with deep experience translating biology into commercial products.
As an early R&D leader at Impossible Foods, she built the company's microbial strain development program and went on to lead R&D and biomanufacturing, helping take recombinant heme from laboratory development to industrial-scale production, including scaling a technically demanding fermentation process to 190,000 liters.
Later, as Chief Business Officer at Fermic, a fermentation manufacturer in Mexico City, she gained a broader view of biomanufacturing across customers, products and industries. At CUVIA she brings these disciplines together to build a new generation of recombinant proteins for research and pharmaceutical applications.

Synthetic Biology Lead
Deep expertise in protein expression, strain engineering, genome editing and assay development.
Before CUVIA he was a Principal Scientist at Impossible Foods, where he discovered regulatory mechanisms that substantially improved recombinant protein production and developed new tools for industrial strain engineering. His broader work spans immunosequencing, RNA biology and gene regulation, and he is a lead inventor on multiple patents and co-author of 10 peer-reviewed publications, including work published in Nature, Nature Communications and PNAS.
At CUVIA he is the key builder of the protein production platform, combining deep host biology with rapid, rigorous experimentation to create strains and expression systems that perform.

Protein Engineering Lead
More than 14 years in protein engineering, enzyme design and biomanufacturing.
At Codexis he was a key contributor to the CodeEvolver® protein engineering platform and a principal technical lead on the ECO Synthesis® platform for enzymatic oligonucleotide manufacturing, with more than 15 patents spanning core platform technologies.
At CUVIA he brings depth in protein design and engineering, expanding the ability to create differentiated proteins with the performance required for real-world manufacturing and commercial applications.